Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia
In patients with hematologic malignancies, acute kidney injury (AKI) is the most common kidney complication requiring nephrologist consultation. Although the causes of AKI are multifactorial, primary tumor infiltration is rare in patients with acute myeloblastic leukemia (AML). This makes it challen...
Gespeichert in:
| Veröffentlicht in: | Journal of Nippon Medical School 2020/02/15, Vol.87(1), pp.43-48 |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 48 |
|---|---|
| container_issue | 1 |
| container_start_page | 43 |
| container_title | Journal of Nippon Medical School |
| container_volume | 87 |
| creator | Aratani, Sae Aburakawa, Sho Ryotokuji, Tsuyoshi Marumo, Atsushi Sakai, Yukinao Inokuchi, Koiti Tsuruoka, Shuichi |
| description | In patients with hematologic malignancies, acute kidney injury (AKI) is the most common kidney complication requiring nephrologist consultation. Although the causes of AKI are multifactorial, primary tumor infiltration is rare in patients with acute myeloblastic leukemia (AML). This makes it challenging to determine the cause of AKI and the optimal chemotherapy regimen for AML. We describe two cases of AML (French-American-British classification: M2, M4) in patients with AKI requiring hemodialysis. We successfully identified the cause of AKI as primary leukemic infiltration and started induction chemotherapy in the setting of hemodialysis. This treatment significantly improved renal function and resulted in AML remission. In this report, we describe several clinical characteristics of AKI due to primary tumor infiltration. In addition, we emphasize the importance of onconephrology, a new subspecialty concerned with the complex relationship between the kidneys and cancer. |
| doi_str_mv | 10.1272/jnms.JNMS.2020_87-108 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_webof</sourceid><recordid>TN_cdi_proquest_miscellaneous_2333926680</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2333926680</sourcerecordid><originalsourceid>FETCH-LOGICAL-c514t-785fc6add985ed50f546e000d6216ed7350184fd49184fc7136726068e567853</originalsourceid><addsrcrecordid>eNqNkV1v2yAUhtG0au26_YRNXE6qnPFhML6son10TbdKzT0i-Hgls3EHuFX-_XCcZdKuesNB4nnhnAeE3lGyoKxiH7e-j4tv32_uFowwolVVUKJeoDPKy6rgJalf7veiKGUlT9HrGLeEcC6EfIVOOa0JU4KdofY2uN6EHV6P_RDwlW9dl4JJbvDY-AbfwSMEwJd2TICvXeNhl6HtmBPO49sMgk8RP7l0f4BudtANm87E5CxewfgLemfeoJPWdBHeHuo5Wn_-tF5-LVY_vlwtL1eFFbRMRaVEa6VpmloJaARpRSmBENJIRiU0FReEqrJtynoqtqJcVkwSqUDInOXn6MN87UMYfo8Qk-5dtNB1xsMwRs045zWTUpGMihm1YYgxQKsfZhOaEj0Z1pNhPRnWB8P5ROXc-8MT46aH5pj6qzQDFzPwBJuhjTYLsnDE8jCCKkGIyrv9der59NKl_c8sh9GnHL2eo9uYzM9_IROy-Q7m_qeup-X_OY6UvTdBg-d_AOzJtAI</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2333926680</pqid></control><display><type>article</type><title>Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia</title><source>J-STAGE Free</source><source>Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /></source><creator>Aratani, Sae ; Aburakawa, Sho ; Ryotokuji, Tsuyoshi ; Marumo, Atsushi ; Sakai, Yukinao ; Inokuchi, Koiti ; Tsuruoka, Shuichi</creator><creatorcontrib>Aratani, Sae ; Aburakawa, Sho ; Ryotokuji, Tsuyoshi ; Marumo, Atsushi ; Sakai, Yukinao ; Inokuchi, Koiti ; Tsuruoka, Shuichi</creatorcontrib><description>In patients with hematologic malignancies, acute kidney injury (AKI) is the most common kidney complication requiring nephrologist consultation. Although the causes of AKI are multifactorial, primary tumor infiltration is rare in patients with acute myeloblastic leukemia (AML). This makes it challenging to determine the cause of AKI and the optimal chemotherapy regimen for AML. We describe two cases of AML (French-American-British classification: M2, M4) in patients with AKI requiring hemodialysis. We successfully identified the cause of AKI as primary leukemic infiltration and started induction chemotherapy in the setting of hemodialysis. This treatment significantly improved renal function and resulted in AML remission. In this report, we describe several clinical characteristics of AKI due to primary tumor infiltration. In addition, we emphasize the importance of onconephrology, a new subspecialty concerned with the complex relationship between the kidneys and cancer.</description><identifier>ISSN: 1345-4676</identifier><identifier>EISSN: 1347-3409</identifier><identifier>DOI: 10.1272/jnms.JNMS.2020_87-108</identifier><identifier>PMID: 31902852</identifier><language>eng</language><publisher>TOKYO: The Medical Association of Nippon Medical School</publisher><subject>acute kidney injury ; acute myeloblastic leukemia ; chemotherapy ; General & Internal Medicine ; Life Sciences & Biomedicine ; Medicine, General & Internal ; onco-nephrology ; Science & Technology ; tumor infiltration</subject><ispartof>Journal of Nippon Medical School, 2020/02/15, Vol.87(1), pp.43-48</ispartof><rights>2020 by the Medical Association of Nippon Medical School</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>true</woscitedreferencessubscribed><woscitedreferencescount>5</woscitedreferencescount><woscitedreferencesoriginalsourcerecordid>wos000518500800008</woscitedreferencesoriginalsourcerecordid><citedby>FETCH-LOGICAL-c514t-785fc6add985ed50f546e000d6216ed7350184fd49184fc7136726068e567853</citedby><cites>FETCH-LOGICAL-c514t-785fc6add985ed50f546e000d6216ed7350184fd49184fc7136726068e567853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,781,785,1884,27929,27930,28253</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31902852$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aratani, Sae</creatorcontrib><creatorcontrib>Aburakawa, Sho</creatorcontrib><creatorcontrib>Ryotokuji, Tsuyoshi</creatorcontrib><creatorcontrib>Marumo, Atsushi</creatorcontrib><creatorcontrib>Sakai, Yukinao</creatorcontrib><creatorcontrib>Inokuchi, Koiti</creatorcontrib><creatorcontrib>Tsuruoka, Shuichi</creatorcontrib><title>Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia</title><title>Journal of Nippon Medical School</title><addtitle>J NIPPON MED SCH</addtitle><addtitle>J Nippon Med Sch</addtitle><description>In patients with hematologic malignancies, acute kidney injury (AKI) is the most common kidney complication requiring nephrologist consultation. Although the causes of AKI are multifactorial, primary tumor infiltration is rare in patients with acute myeloblastic leukemia (AML). This makes it challenging to determine the cause of AKI and the optimal chemotherapy regimen for AML. We describe two cases of AML (French-American-British classification: M2, M4) in patients with AKI requiring hemodialysis. We successfully identified the cause of AKI as primary leukemic infiltration and started induction chemotherapy in the setting of hemodialysis. This treatment significantly improved renal function and resulted in AML remission. In this report, we describe several clinical characteristics of AKI due to primary tumor infiltration. In addition, we emphasize the importance of onconephrology, a new subspecialty concerned with the complex relationship between the kidneys and cancer.</description><subject>acute kidney injury</subject><subject>acute myeloblastic leukemia</subject><subject>chemotherapy</subject><subject>General & Internal Medicine</subject><subject>Life Sciences & Biomedicine</subject><subject>Medicine, General & Internal</subject><subject>onco-nephrology</subject><subject>Science & Technology</subject><subject>tumor infiltration</subject><issn>1345-4676</issn><issn>1347-3409</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AOWDO</sourceid><recordid>eNqNkV1v2yAUhtG0au26_YRNXE6qnPFhML6son10TbdKzT0i-Hgls3EHuFX-_XCcZdKuesNB4nnhnAeE3lGyoKxiH7e-j4tv32_uFowwolVVUKJeoDPKy6rgJalf7veiKGUlT9HrGLeEcC6EfIVOOa0JU4KdofY2uN6EHV6P_RDwlW9dl4JJbvDY-AbfwSMEwJd2TICvXeNhl6HtmBPO49sMgk8RP7l0f4BudtANm87E5CxewfgLemfeoJPWdBHeHuo5Wn_-tF5-LVY_vlwtL1eFFbRMRaVEa6VpmloJaARpRSmBENJIRiU0FReEqrJtynoqtqJcVkwSqUDInOXn6MN87UMYfo8Qk-5dtNB1xsMwRs045zWTUpGMihm1YYgxQKsfZhOaEj0Z1pNhPRnWB8P5ROXc-8MT46aH5pj6qzQDFzPwBJuhjTYLsnDE8jCCKkGIyrv9der59NKl_c8sh9GnHL2eo9uYzM9_IROy-Q7m_qeup-X_OY6UvTdBg-d_AOzJtAI</recordid><startdate>20200215</startdate><enddate>20200215</enddate><creator>Aratani, Sae</creator><creator>Aburakawa, Sho</creator><creator>Ryotokuji, Tsuyoshi</creator><creator>Marumo, Atsushi</creator><creator>Sakai, Yukinao</creator><creator>Inokuchi, Koiti</creator><creator>Tsuruoka, Shuichi</creator><general>The Medical Association of Nippon Medical School</general><general>Medical Assoc Nippon Medical Sch</general><scope>AOWDO</scope><scope>BLEPL</scope><scope>DTL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20200215</creationdate><title>Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia</title><author>Aratani, Sae ; Aburakawa, Sho ; Ryotokuji, Tsuyoshi ; Marumo, Atsushi ; Sakai, Yukinao ; Inokuchi, Koiti ; Tsuruoka, Shuichi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c514t-785fc6add985ed50f546e000d6216ed7350184fd49184fc7136726068e567853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>acute kidney injury</topic><topic>acute myeloblastic leukemia</topic><topic>chemotherapy</topic><topic>General & Internal Medicine</topic><topic>Life Sciences & Biomedicine</topic><topic>Medicine, General & Internal</topic><topic>onco-nephrology</topic><topic>Science & Technology</topic><topic>tumor infiltration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aratani, Sae</creatorcontrib><creatorcontrib>Aburakawa, Sho</creatorcontrib><creatorcontrib>Ryotokuji, Tsuyoshi</creatorcontrib><creatorcontrib>Marumo, Atsushi</creatorcontrib><creatorcontrib>Sakai, Yukinao</creatorcontrib><creatorcontrib>Inokuchi, Koiti</creatorcontrib><creatorcontrib>Tsuruoka, Shuichi</creatorcontrib><collection>Web of Science - Science Citation Index Expanded - 2020</collection><collection>Web of Science Core Collection</collection><collection>Science Citation Index Expanded</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of Nippon Medical School</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aratani, Sae</au><au>Aburakawa, Sho</au><au>Ryotokuji, Tsuyoshi</au><au>Marumo, Atsushi</au><au>Sakai, Yukinao</au><au>Inokuchi, Koiti</au><au>Tsuruoka, Shuichi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia</atitle><jtitle>Journal of Nippon Medical School</jtitle><stitle>J NIPPON MED SCH</stitle><addtitle>J Nippon Med Sch</addtitle><date>2020-02-15</date><risdate>2020</risdate><volume>87</volume><issue>1</issue><spage>43</spage><epage>48</epage><pages>43-48</pages><issn>1345-4676</issn><eissn>1347-3409</eissn><abstract>In patients with hematologic malignancies, acute kidney injury (AKI) is the most common kidney complication requiring nephrologist consultation. Although the causes of AKI are multifactorial, primary tumor infiltration is rare in patients with acute myeloblastic leukemia (AML). This makes it challenging to determine the cause of AKI and the optimal chemotherapy regimen for AML. We describe two cases of AML (French-American-British classification: M2, M4) in patients with AKI requiring hemodialysis. We successfully identified the cause of AKI as primary leukemic infiltration and started induction chemotherapy in the setting of hemodialysis. This treatment significantly improved renal function and resulted in AML remission. In this report, we describe several clinical characteristics of AKI due to primary tumor infiltration. In addition, we emphasize the importance of onconephrology, a new subspecialty concerned with the complex relationship between the kidneys and cancer.</abstract><cop>TOKYO</cop><pub>The Medical Association of Nippon Medical School</pub><pmid>31902852</pmid><doi>10.1272/jnms.JNMS.2020_87-108</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1345-4676 |
| ispartof | Journal of Nippon Medical School, 2020/02/15, Vol.87(1), pp.43-48 |
| issn | 1345-4676 1347-3409 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2333926680 |
| source | J-STAGE Free; Web of Science - Science Citation Index Expanded - 2020<img src="https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg" /> |
| subjects | acute kidney injury acute myeloblastic leukemia chemotherapy General & Internal Medicine Life Sciences & Biomedicine Medicine, General & Internal onco-nephrology Science & Technology tumor infiltration |
| title | Primary Tumor Infiltration and Severe Acute Kidney Injury in Patients with Acute Myeloblastic Leukemia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-14T21%3A36%3A18IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_webof&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Primary%20Tumor%20Infiltration%20and%20Severe%20Acute%20Kidney%20Injury%20in%20Patients%20with%20Acute%20Myeloblastic%20Leukemia&rft.jtitle=Journal%20of%20Nippon%20Medical%20School&rft.au=Aratani,%20Sae&rft.date=2020-02-15&rft.volume=87&rft.issue=1&rft.spage=43&rft.epage=48&rft.pages=43-48&rft.issn=1345-4676&rft.eissn=1347-3409&rft_id=info:doi/10.1272/jnms.JNMS.2020_87-108&rft_dat=%3Cproquest_webof%3E2333926680%3C/proquest_webof%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2333926680&rft_id=info:pmid/31902852&rfr_iscdi=true |